Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Jan 31, 2025
Date Accepted: Sep 29, 2025

The final, peer-reviewed published version of this preprint can be found here:

Experiences of Cancer-Related Cognitive Impairment Across Cancer Types: Qualitative Systematic Review

Ibrar M, Rai HK, Main A, McCartney H, Parra MA, Maguire R

Experiences of Cancer-Related Cognitive Impairment Across Cancer Types: Qualitative Systematic Review

JMIR Cancer 2025;11:e71996

DOI: 10.2196/71996

PMID: 41172302

PMCID: 12619018

The Experience of Cancer-Related Cognitive Impairment Across Cancer Type: A Qualitative Systematic Review

  • Maryam Ibrar; 
  • Harleen Kaur Rai; 
  • Ashleigh Main; 
  • Haruno McCartney; 
  • Mario A Parra; 
  • Roma Maguire

ABSTRACT

Background:

Cancer-related cognitive impairment (CRCI) is frequently reported during cancer treatment, with 35% experiencing cognitive issues even after treatment completion. Commonly reported impairments include difficulties with memory, attention, executive functioning, and processing speed, which often detract from daily functioning and quality of life (QoL). Despite its prevalence, CRCI remains under-researched across common cancers, limiting understanding of the patient experience. This review aims to examine the evidence regarding the experience of CRCI across common cancers. It also aims to understand the frequency of CRCI among different cancer types, the affected cognitive domains, and its impact on QoL and functional ability.

Objective:

This qualitative systematic review aims to examine the evidence regarding the experience of CRCI across common cancers. It also aims to understand the frequency of CRCI among different cancer types, the affected cognitive domains, and its impact on QoL and functional ability.

Methods:

A systematic review was conducted using PRISMA methodology (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). A comprehensive search of databases, including PubMed, APA PsycInfo, CINAHL, and Scopus, was performed. Articles relating to the experience of CRCI using qualitative/ mixed methods were included. Two independent reviewers screened titles, abstracts, and full texts, with a third reviewer resolving conflicts during the inclusion process. The CASP (Critical Appraisal Skills Programme) checklist was used for data extraction and quality assessment. The data were analysed using thematic analysis.

Results:

The database search identified 9,316 papers; 41 were included for analysis. The analysis revealed 4 themes. “Cognitive Challenges”, explores the impacted cognitive domains such as memory and concentration; “Navigating Employment”, discusses challenges associated with return to work, support, and disclosure; “Emotional, Behavioural, and Psychological Impacts”, explores emotional and psychological responses; and “Support Systems”, emphasises the role of social and healthcare support.

Conclusions:

This qualitative systematic review highlights the significant disruption CRCI causes in daily life, stressing the need for increased awareness, standardised screening, and further research into digital interventions. Improved management of CRCI can support cancer survivors reintegrate into their daily lives and employment.


 Citation

Please cite as:

Ibrar M, Rai HK, Main A, McCartney H, Parra MA, Maguire R

Experiences of Cancer-Related Cognitive Impairment Across Cancer Types: Qualitative Systematic Review

JMIR Cancer 2025;11:e71996

DOI: 10.2196/71996

PMID: 41172302

PMCID: 12619018

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.